Elecsys® HSV-2 Igin human serum and plasma herpes simplex virus type 2 (HSV-2)‘specific IgG class antibodies High sensitivity developed for qualitative detection immunological test. Test in sexually active individuals and pregnant HSV-2 pre-diagnosis of infection is used to help.
This test, electrokimiluemia immunooassay (ECLIA) uses technology and cobas e immunoassay analyzers fully compatible with:
- cobas e 801
- cobas e 402
- cobas e 411
- cobas e 602
- cobas e 601
Clinical Use and Advantages
Elecsys HSV-2 Ig, HSV-2 is an effective solution for determining the condition of exposure to infection. Test, especially pregnant and in active individuals HSV-2Helps identify immune status against . This is especially during the prenatal period HSV-2’ plays a critical role in clinical decision processes to prevent neonatal complications.
The advantages of the test are:
- High personality and sensitivity with reliable results
- Selective detection of IgG antibodies, HSV-2Shows the history of immunity specific to .
- ECLIA technology with quick, automatic and standard results
- Serum, lithium-heparin plasma, K2-EDTA and K3-EDTA plasma applicability in examples
Clinical Limitations
- This test, HSV-2’s active infection period or presence of lesions It is not used directly to determine.
- Initial infection (primer infection) In the case, additional tests may be required for diagnosis.
- The accuracy of the test is in the population to be applied HSV-2 prevalan and patient Pre-test possibility closely associated with it.
- In pediatric individuals, in newborns, In patients with immunocompromize and maintenance at point (POC• in environments not corrected for use.
- Can not be used for screening in blood and plasma donors.
Reliable Test Performance
Elecsys HSV-2 Ig, in vitro diagnosis used for purpose and routine laboratory environments High workflow consistency. Cobas e platforms Working fully integrated with, it provides high efficiency with user-friendly interface and minimum operator intervention.
